Clinically, our findings emphasize the need to consider MHC II deficiency in infants with recurrent infections, profound CD4 lymphopenia, and reduced HLA-DR expression, particularly in consanguineous families or those with affected siblings. This evidence concerns the gene CD4 and hyperinsulinemic hypoglycemia, familial, 4.